Imualfa 1.6mg Injection
By Imualfa
Rx
1 Injection in a Vial

Composition
Thymosin alpha(1.6mg)

Manufacturer - Alniche Life Sciences Pvt Ltd
Alniche Life Sciences Pvt. Ltd., S-14, 2nd Floor, Janta Market Rajouri Garden, New Delhi – 110 027

Expires on or after
April, 2026

liver
Imualfa 1.6mg Injection is considered safe for use in individuals with liver disease. Current data indicates that adjusting the dosage of Imualfa 1.6mg Injection may not be necessary for patients with liver conditions. It is recommended to seek guidance from your healthcare provider before using this medication, especially if you have liver issues.

kidney
Limited information is present regarding the use of Imualfa 1.6mg Injection in patients with kidney disease. It is advisable to consult with your doctor for guidance.

alcohol
It is not known whether drinking alcohol is safe while using Imualfa 1.6mg Injection. Please consult your doctor.

driving
It is uncertain if Imualfa 1.6mg Injection impacts driving ability. Avoid driving if you have symptoms hindering focus and reactions.

pregnancy
Imualfa 1.6mg Injection is considered unsafe for use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor for more information.

breastfeeding
It is better to consult your doctor before using Imualfa 1.6mg Injection.
Habit Forming | No |
Chemical Class | Peptides |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Biological response modifier- Thymosin alpha |
₹2400
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025